Table 2.
Group | Horses | Vaccine | Protein content | Dose and route of administration |
---|---|---|---|---|
1 | Horse 1 Horse 2 |
Gradient purified AHS 5 VLPs | AHSV 5 VP2, VP3, VP5 and VP7 | ± 200 μg total protein in 5 mL PBS pH 7.4 with 5% Pet Gel A adjuvant, intra-muscular |
2 | Horse 3 Horse 4 |
Filtered AHS 5 VLPs | AHSV 5 VP2, VP3, VP5 and VP7 | ± 100 μg total protein in 5 mL bicine buffer pH 8.5 with 5% Pet Gel A adjuvant, intra-muscular |
3 | Horse 5 Horse 6 |
PBS | Nil | 5 mL PBS pH 7.4 with 5% Pet Gel A adjuvant, intra-muscular |
4 | Horse 7 Horse 8 |
Bicine | Nil | 5 mL bicine buffer pH 8.5 with 5% Pet Gel A adjuvant, intra-muscular |
Horses were vaccinated with either gradient-purified (Group 1) or filtered (Group 2) plant-produced AHS 5 VLPs, or PBS (Group 3) or bicine buffer (Group 4), all adjuvanted with 5% Pet Gel A (SEPPIC, Paris, France) and administered by deep intra-muscular injection.